News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Brammer Bio has completed renovations at its gene therapy manufacturing facility in Cambridge, MA amid industrywide capacity concerns as more biologics enter late-stage clinical trials.
Opinion
The UK government has outlined its industrial strategy as it prepares to leave the European Union and boasts of investments and collaborations driving the life science sector.
Bluebird bio has acquired a North Carolina manufacturing facility to produce lentiviral vectors for its cell and gene therapy candidates.
Thermo Fisher will up its list prices by an average of 3.3% across much of its early-stage bioproduction product range, reflecting changing market conditions.
Gritstone Oncology has opened a manufacturing plant in California to make personalised cancer immunotherapies.